Product Image
Please see full prescribing and safety information, including boxed warning, for OXALIPLATIN vials.

Available in:

  • 50 mg per 10 mL single-use vials
  • 100 mg per 20 mL single-use vials


  • AP Rated
  • Preservative-free
  • Not made with natural rubber latex


Brand Name Equivalent: ELOXATIN® (ELOXATIN is a registered trademark of Sanofi-Aventis U.S. LLC.)
Therapeutic Category: Antineoplastic Agent

PreventIV MeasuresTM Features:

  • Easy-to-read drug name and dosage strength to aid in identifying the right product
  • Bar codes included on the vial and carton for ease of scanning
  • Unique label design to help products stand out on the shelf
  • Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
  • Yellow and black cytotoxic caution flag designed to alert healthcare workers who handle the product
Description Strength Fill
Concentration Container
Closure Unit
of Sale
233-10 Glass Vial 50 mg 10 mL 5 mg per mL 20 mL 20 mm 1
233-20 Glass Vial 100 mg 20 mL 5 mg per mL 20 mL 20 mm 1
Anaphylactic reactions to Oxaliplatin Injection, USP have been reported, and may occur within minutes of Oxaliplatin Injection, USP administration. Epinephrine, corticosteroids, and antihistamines have been employed to alleviate symptoms of anaphylaxis [see Warnings and Precautions (5.1)].